Cargando…
Forskolin attenuates doxorubicin-induced accumulation of asymmetric dimethylarginine and s-adenosylhomocysteine via methyltransferase activity in leukemic monocytes
Doxorubicin (DOX) is an antitumor drug, associated with cardiomyopathy. Strategies to address DOX-cardiomyopathy are scarce. Here, we identify the effect of forskolin (FSK) on DOX-induced-asymmetric-dimethylarginine (ADMA) accumulation in monocytoid cells. DOX-challenge led to i) augmented cytotoxic...
Autores principales: | Ramachandran, Sandhiya, Loganathan, Swetha, Cheeran, Vinnie, Charles, Soniya, Munuswamy-Ramanujan, Ganesh, Ramasamy, Mohankumar, Raj, Vijay, Mala, Kanchana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993357/ https://www.ncbi.nlm.nih.gov/pubmed/29892545 http://dx.doi.org/10.1016/j.lrr.2018.02.001 |
Ejemplares similares
-
Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletion
por: Toubhans, Benoit, et al.
Publicado: (2023) -
S-adenosylhomocysteine hydrolase over-expression does not alter S-adenosylmethionine or S-adenosylhomocysteine levels in CBS deficient mice
por: Lee, Hyung-Ok, et al.
Publicado: (2018) -
Intracerebral Administration of S-Adenosylhomocysteine or S-Adenosylmethionine Attenuates the Increases in the Cortical Extracellular Levels of Dimethylarginines Without Affecting cGMP Level in Rats with Acute Liver Failure
por: Czarnecka, Anna, et al.
Publicado: (2016) -
Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine
por: Xiao, Jinghe, et al.
Publicado: (2022) -
Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase
por: Singhal, Anshika, et al.
Publicado: (2013)